Bristol Myers Squibb (BMY) Share-based Compensation Growth (5y) (2014 - 2026)

Bristol Myers Squibb (BMY) Share-based Compensation Growth (5y) (2014 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.67%
Dec 31, 2025 -4.90%
Sep 30, 2025 -5.56%
Jun 30, 2025 -8.45%
Mar 31, 2025 -7.27%
Dec 31, 2024 -15.83%
Sep 30, 2024 18.16%
Jun 30, 2024 21.10%
Mar 31, 2024 20.20%
Dec 31, 2023 19.10%
Sep 30, 2023 16.32%
Jun 30, 2023 21.85%
Mar 31, 2023 17.27%
Dec 31, 2022 18.94%
Sep 30, 2022 18.13%
Jun 30, 2022 16.52%
Mar 31, 2022 18.91%
Dec 31, 2021 18.89%
Sep 30, 2021 24.23%
Jun 30, 2021 23.79%